google.com, pub-1967056301068318, DIRECT, f08c47fec0942fa0 mgid.com, 288776, DIRECT, d4c29acad76ce94f
Ayo Vaksin
Selasa, 27 Juli 2021 11:14:00

EVA Pharma: Supporting India Amid COVID-19 Surge

CAIRO, EGYPT - EQS Newswire - 27 July 2021 - EVA Pharma's (www.EVAPharma.com) timely shipments of Remdesivir reached India during a major wave of coronavirus cases.

When India experienced an unexpected COVID-19 surge this spring, the rapid increase in cases put pressure on the local pharmaceutical industry to supply the medicines needed. In April, EVA Pharma signed a contract with the Indian government to export 300,000 vials of Remdesivir, an approved treatment for coronavirus, to meet the urgent needs there.

Six shipments of Remdesivir were flown to Mumbai between May and June and were subsequently dispatched to hospitals across India, reaching patients everywhere from major cities to the remote archipelago of Lakshadweep.

"I'm glad to say that the six consignments in which the Remdesivir was dispatched to India were not only sent on schedule but in all cases before the schedule," commented Ambassador Ajit Gupte, India's envoy to Egypt. "This was a period when the caseload was very high in India, and the shipments would have helped to save a lot of lives."

EVA Pharma is the only company in the Middle East or Africa that has been granted a voluntary license to produce and distribute Remdesivir by Gilead Sciences, Inc, the owner of the molecule. The production lines at the EVA Pharma facility in Haram, Cairo, are certified by the European Medicines Agency (EMA), enabling the company to export its products globally.

COVID-19 cases in India have since declined, reducing the immediate pressure on local health systems and supply lines. Cases in other countries have gone up in recent months, however, especially due to the spread of the Delta variant. As a result, EVA Pharma has increased its exports of Remdesivir to other Asian countries such as Indonesia.

"We are proud to support COVID-19 efforts both in Egypt and around the world by manufacturing Remdesivir at our world-class manufacturing facility in Cairo," said Dr. Riad Armanious, CEO of EVA Pharma. "With our monthly production of Remdesivir now amounting to 1.5 million doses, we are able to meet the local needs of Egyptian patients while also helping other countries tackle this crisis. In fact, we now supply more than 20 countries around the world with Remdesivir."

The success of the cooperation between EVA Pharma and India highlights the potential for further fruitful collaboration between emerging economies, especially during times of need.

"As developing countries, what I can say is India and Egypt face similar challenges," said Ambassador Gupte. "One of the challenges we face is how we can provide affordable health care to our millions of people because we are populous countries. Cost is important. So I think the closer the cooperation between India and Egypt, the more we will be able to help provide basic needs for the people of our countries."



About EVA Pharma

EVA Pharma, one of the major multinational pharmaceutical companies headquartering in Cairo, Egypt while operating in more than 40 countries and one of the fastest-growing pharmaceutical companies in the MENA region. The company has partnerships with some of the leading international pharmaceutical names the world over and has a presence in 41 countries throughout the region. With a 3,000-strong team of some of the region's most competent pharmaceutical professionals, EVA Pharma produces an average of 350,000 packs of more than 185 different drugs daily. Its state-of-the-art facilities are equipped with cutting-edge technology and are internationally recognized for innovation and the highest international quality standards.

To learn more about EVA Pharma, please visit: www.EVAPharma.com

Download image 1: https://bit.ly/2VbHDyz

Download image 2: https://bit.ly/2Vdfd78

Download image 3: https://bit.ly/3rC69EZ

Download image 4: https://bit.ly/3iTQ8X9

Video: https://bit.ly/2UU0tdv

Share
Berita Terkait
  • 7 jam lalu

    Indra Gunawan Resmi jadi Sekda Kota Dumai

    Proses seleksi Jabatan Pimpinan Tinggi Pratama Sekretaris Daerah Kota Dumai dijamin berjalan sesuai koridor tanpa intervensi dari pihak manapun. ASN yang memenuhi persyaratan memil
  • 7 jam lalu

    Tiga Jenis Vaksin masih Tersedia di Kota Dumai

    Guna memaksimalkan kegiatan vaksinasi, Pemerintah Dumai melalui gugus tugas dan Dinas Kesehatan menjelaskan bahwa ketersediaan vaksin di Dumai masih aman. Tiga jenis vaksin masih t
  • 4 hari lalu

    Pemerintah Dumai Bersama Polres Dumai Gelar Vaksinasi Presisi Massal

    Vaksin presisi merupakan vaksinasi massal yang dibuka untuk masyarakat Kota Dumai maupun yang diluar Kota Dumai. Terutama masyarakat yang belum mendapatkan vaksin tersebut.
  • 7 jam lalu

    Hong Kong Convention Ambassadors' Tech Event Wins Underline the City's Position as a Pivotal I&T Hub

    Through the HKCA programme, the HKTB provides one-stop event support for events both large and small for the I&T sector, as well other business and professional fields, and promote
  • Komentar
    Copyright © 2021 Global Riau - Berita Riau Hari Ini. All Rights Reserved.
     
    loading...
    google.com, pub-1967056301068318, DIRECT, f08c47fec0942fa0 mgid.com, 288776, DIRECT, d4c29acad76ce94f